36th EDRN Steering Committee Meeting - Tuesday 27 October Agenda

Agenda for Tuesday, October 27th, for the 36th EDRN Steering Committee Meeting

11:00 a.m. - 11:05 a.m. (all times Eastern Daylight Time)

Welcome and Opening of the October 2020 EDRN Steering Committee Meeting
Joshua LaBaer, M.D., Ph.D., Arizona State University/The Biodesign Institute

11:05 a.m. - 11:15 a.m. EDT

Opening Remarks

Philip E. Castle, Ph.D., M.P.H.,
Director, Division of Cancer Prevention, National Cancer Institute

01-Charge to Participants
Sudhir Srivastava, Ph.D., M.P.H., National Cancer Institute

11:15 a.m. - 1:10 p.m. EDT

Session 1 - What Target Sensitivity and Specificity Might Confer Clinical Utility?

  • Steve Skates, Ph.D., Massachusetts General Hospital/Harvard
  • Robert Schoen, M.D., University of Pittsburgh Cancer Institute
NCI Program Directors:
  • Jacob Kagan, Ph.D., M.Sc.
  • Lynn Sorbara, Ph.D.
Note Takers:
  • Steve Skates and Lynn Sorbara
11:15 a.m. - 11:30 a.m. EDT

02-Ovarian Cancer
Steven Skates, Ph.D., Massachusetts General Hospital/Harvard

11:30 a.m. - 11:35 a.m. EDT


11:35 a.m. - 11:50 a.m. EDT

03-Prostate Cancer
Martin Sanda, M.D., Emory University

11:50 a.m. - 11:55 a.m. EDT


11:55 a.m. - 12:10 p.m. EDT

04-Pancreatic Cancer
Randall Brand, M.D., University of Pittsburgh

12:10 p.m. - 12:15 p.m. EDT


12:15 p.m. - 12:30 p.m. EDT

05-Colon Cancer
Uri Ladabaum, M.D., Stanford University School of Medicine

12:30 p.m. - 12:35 p.m. EDT


12:35 p.m. - 12:50 p.m. EDT

06-Lung Cancer
Harry de Koning, M.D., Ph.D., Erasmus University Medical Centre

12:50 p.m. - 12:55 p.m. EDT


12:55 p.m. - 1:15 p.m. EDT

Further Discussion

1:15 p.m. - 1:20 p.m. EDT


1:20 p.m. - 3:20 p.m. EDT

Session 2 - Modeling, Biomarkers and Implementation Science

  • Ziding Feng, Ph.D., Fred Hutchinson Cancer Research Center
  • Ruth Etzioni, Ph.D., Fred Hutchinson Cancer Research Center
NCI Program Directors:
  • Christos Patriotis, Ph.D.
  • Matt Young, Ph.D.
Note Takers:
  • Ruth Etzioni and Christos Patriotis
1:20 p.m. - 1:40 p.m. EDT

07-Combining Biomarkers with Lung Cancer Low-Dose CT Screening - Assessing Potential Impact Via Simulation Modeling
Rafael Meza, Ph.D., University of Michigan

1:40 p.m. - 1:45 p.m. EDT


1:45 p.m. - 2:05 p.m. EDT

08-Asking the Right Questions: Modeling Risk Stratification and Novel Biomarkers for Prostate Cancer
Ruth Etzioni, Ph.D., Fred Hutchinson Cancer Research Center

2:05 p.m. - 2:10 p.m. EDT


2:10 p.m. - 2:30 p.m. EDT

09-Elements of Prediction: CRC Screening, New Biomarkers, and Comparative Effectiveness
Carolyn Rutter, Ph.D., RAND Corporation

2:30 p.m. - 2:35 p.m. EDT


2:35 p.m. - 2:55 p.m. EDT

10-Barriers to Effective Hepatocellular Carcinoma Surveillance and Potential Role of Biomarkers
Amit Singal, M.D., The University of Texas Southwestern Medical Center

2:55 p.m. - 3:00 p.m. EDT


3:00 p.m. - 3:20 p.m. EDT

Future Directions

3:20 p.m. - 3:30 p.m. EDT


3:30 p.m. - 6:00 p.m. EDT

Session 3 - Health Disparity and Biomarker Research

  • Christopher Li, M.D., Ph.D., Fred Hutchinson Cancer Research Center
  • Martin Sanda, M.D., Emory University
  • Pierre Massion, M.D., Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
NCI Program Directors:
  • Jo Ann Rinaudo, Ph.D.
  • Sharmistha Ghosh-Janjigian, Ph.D.
Note Takers:
  • Christopher Li and Sharmistha Ghosh-Janjigian
3:30 p.m. - 3:35 p.m. EDT

Introduction by Session Moderators

3:35 p.m. - 3:45 p.m. EDT

11-CRCHD Funding Opportunity for EDRN Investigators
Anil Wali, Ph.D., Program Director, Center to Reduce Cancer Health Disparities (CRCHD), National Cancer Institute

3:45 p.m. - 3:50 p.m. EDT


3:50 p.m. - 4:10 p.m. EDT

12-Increasing Colorectal Cancer Screening and Follow-up through Partnerships with Community Health Centers
Elena Martinez, Ph.D., Associate Director, Population Science, Disparities and Community Engagement, University of California, San Diego

4:10 p.m. - 4:15 p.m. EDT


4:15 p.m. - 4:20 p.m. EDT


4:20 p.m. - 4:40 p.m. EDT

13-Keynote Presentation: Prostate Cancer Detection and Health Disparities
Otis Brawley, M.D., Bloomberg Distinguished Professor of Oncology and Epidemiology at the Sidney Kimmel Comprehensive Cancer Center, School of Medicine and Department of Epidemiology, Bloomberg School of Public Health of Johns Hopkins University

4:40 p.m. - 4:45 p.m. EDT


4:45 p.m. - 5:05 p.m. EDT

14-Lung Cancer Health Disparity and Screening
Robert Winn, M.D., Director, Massey Cancer Center, Virginia Commonwealth University

5:05 p.m. - 5:10 p.m. EDT


5:10 p.m. - 5:30 p.m. EDT

15-Biological Determinants of Breast Cancer Disparities
Melissa Davis, Ph.D., Assistant Professor, Weill Cornell Medicine

5:30 p.m. - 5:35 p.m. EDT


5:35 p.m. - 6:00 p.m. EdT

Panel Discussion

6:00 p.m. EDT

Adjourn for the Day

Version 5.1.0